Thomas Rowland - 12 Feb 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIP	Common Stock	Award	$0	+7.83K	+23.3%	$0.00	41.5K	12 Feb 2025	Direct	F1, F2
transaction	ANIP	Common Stock	Award	$0	+5.22K	+12.6%	$0.00	46.7K	12 Feb 2025	Direct	F3
transaction	ANIP	Common Stock	Tax liability	-$34.3K	-582	-1.25%	$58.92	46.1K	14 Feb 2025	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
F2	Includes 449 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).
F3	These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
F4	Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,677 shares of restricted stock, the grant of which was previously reported.